9h
GlobalData on MSNEMA establish advisory portal for high-risk medical devicesThe EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed ...
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...
1 Christoffersen M et al. Transthyretin Tetramer Destabilization and Increased Mortality in the General Population. JAMA ...
USD/JPY traders eye Japan’s machine tool orders and US CPI data for market direction. Will softer inflation revive Fed rate ...
The EUR/JPYhits a multi-week low on the strong yen. It hit a low of 155.49 and is currently trading around 156.95.The ...
GOMEKLIâ„¢ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
EUR/USD rises to near 1.0330 in Tuesday’s North American session as the US Dollar (USD) drops ahead of the Federal Reserve (Fed) Chair Jerome Powell’s testimony before Congress at 15:00 GMT. The US ...
Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...
The euro has gapped lower to kick off the trading week, as we continue to see a lot of volatility in this pair. <li /> As it is likely t ...
The cryptocurrency market has continued to show resilience in the wake of trade tensions. Most majors have recorded some ...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results